Skip to content
National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Division of Cancer Prevention logo
Home Site Map Contact DCP
Programs & Resources

NCI Community Oncology Research Program (NCORP)

Examples of NCI-Sponsored Cancer Care Delivery Research Studies

This list of clinical trials is not intended to be all-inclusive. Rather it is intended to provide you with most of the trials considered Cancer Care Delivery Research (CCDR) in the NCI CCOP program over approximately the last 6 years.

Definition of CCDR: How social factors, financing systems, organizational structures/processes, health technologies, and healthcare provider and individual behaviors affect:

  • cancer outcomes
  • access to and quality of care
  • cancer care costs
  • health and well-being of cancer patients and survivors

Should you have a question identifying a trial as CCDR that is not on this list, please submit it using the NCORP Question Form at: http://prevention.cancer.gov/ncorp#form.

CCOP CCDR Clinical Trials: 2007 to present

Alliance
A011104 Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
CALGB
CALGB-70604 A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer
CALGB-70501 Collection of Patient-Reported Symptoms and Performance Status Via the Internet
COG
COG-AALL03N1 Understanding the Role of Adherence in the Ethnic Differences in Survival After Childhood ALL
COG-ACCL1033 A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
ECOG
E1Q11 EROS: Engendering Reproductive Health within Oncologic Survivorship
E2Z02 SOAPP (Symptom Outcomes and Practice Patterns): A Survey of Disease and Treatment-Related Symptoms in Patients with Invasive Cancer of the Breast, Prostate, Lung or Colon/Rectum
GOG
GOG-0247 Patient, Physician and Nurse Factors Associated with Entry Onto Clinical Trials and Completion of Treatment for Women with Primary or Recurrent Invasive Cancer of the Uterine Corpus or Uterine Cervix, All Stages
GOG-0259 Nurse-Delivered WRITE Symptoms vs. Self-Directed WRITE Symptoms vs. Care as Usual for Optimal Symptom Management for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
GOG-8030 A Comparative Effectiveness Study of Cancer Risk Management for Women at Elevated Genetic Risk of Ovarian Cancer
GOG-0267 Quality of Life and Care Needs in Patients with Persistent or Recurrent Platinum-Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
NSABP
NSABP-DMP-1 A Study to Evaluate Different Decision-Making Approaches Used by Women Known to be at Increased Risk for Breast Cancer
SunCoast
SCUSF-1102 A Cluster Randomized Controlled Trial Comparing Interventions to Enhance Utilization of Genetics Services Among Breast Cancer Patients
SCUSF-1201 Cotinine Feedback as an Intervention to change Parental/Caregiver Smoking Behavior around Children with Cancer
SWOG
S1105 Randomized Trial of Text-Messaging Intervention to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women with Early Stage Breast Cancer
S1204 A Sero-Epidemiologic Survey and Cost-Effectiveness Study of Screening for Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Among Newly Diagnosed Cancer Patients
URCC
URCC-13059 A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy for Advanced Cancer: Reducing Chemotherapy Toxicity in Older Adults
WFU
WFU-99211 Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Lung Cancer Patients Receiving Outpatient Treatment: A Pilot Study


Back to top